Valero, V., Tang, G., Rastogi, P., Geyer, C. E., Colangelo, L. H., Kengla, A. T., Irvin, W. J., Socoteanu, M. P., Abraham, J., Esparaz, B. T., Alguire, K. B., Flaherty, L. E., Jatoi, I., Telli, M. L., Makhoul, I., Freeman, T., Yothers, G., Swain, S. M., Mamounas, E. P., Wolmark, N. (2025). NRG-BR003: A randomized phase III trial comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative TNBC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba509